New frontiers in neuro-oncology

Rapid scientific advancements in neuro-oncology are changing our understanding of glioblastoma brain cancers and tumor-associated epilepsy, paving the way for novel pharmacologic and neuromodulation strategies. Axion’s versatile Maestro systems offer a simple solution for neuro-oncology, allowing scientists to use one platform for disease research and therapeutic discovery.

Featured on this page:

• >> Coffee Break Webinars
• >> Publications
• >> Application Notes
• >> In the News

Simplify your neuro-oncology research with one platform.

Modeling complex cellular interactions and neuronal activity in vitro can be challenging for researchers seeking new ways to manage seizures and improve outcomes for people with brain cancer. Discover how the Maestro platform allows you to do both with one platform—with no labels, dyes, or complicated steps.

>>  Evaluate immunotherapies with Axion’s label-free cell growth and killing assays from discovery to manufacturing.

>>  Explore the underlying mechanisms of glioma seizurogenesis and assess novel therapeutics with Axion’s next-generation assays.

Coffee Break Webinars

Sit back with a cup of coffee and enjoy these 10 minute webinars.

Coffee Break Webinar

Remodeling of human neural circuits by glioblastoma

Author: Saritha Krishna, PhD

Product: Maestro Pro, Neural Module, CytoView MEA Plate,

Coffee Break Webinar

Brain tumors that cause epilepsy

Author: Armin Mortazavi

Product: Maestro Pro, Neural Module, CytoView MEA Plate,